Nasal Swab Remedy for Kids Recalled for Microbial Contamination
Allergy Bee Gone for Kids Nasal Swab Remedy is recalled due to FDA-confirmed microbial contamination including yeast, mold, and Bacillus cereus. Affected consumers should stop using the product.
What this means for you
Highest-severity recall. Risk of serious injury or death is documented or strongly suspected. Stop using the product now and follow the agency's instructions.
Our severity reasoning: The FDA classified this as a Class I recall. Per the severity rubric, FDA Class I recalls are designated as Critical severity, indicating a reasonable probability of causing serious adverse health consequences.
Plain-English summary
Allergy Bee Gone for Kids Nasal Swab Remedy, 0.33 FL OZ (10 mL) tubes, is being recalled due to microbial contamination. FDA laboratory analysis found the product to contain elevated levels of yeast and mold, as well as the presence of Bacillus cereus. The product is non-sterile and unsafe for use.
The recalled product is identified by Lot #2006491 with an expiration date of 08/24. Approximately 28,328 tubes were distributed via the internet to consumers, retailers, and distributors. The product is manufactured by Buzzagogo, LLC and carries UPC code 860002022116.
Consumers who have this product should stop using it immediately. For additional information or to report adverse effects, consumers should contact the FDA.
The recalled product
- Product
- Allergy Bee Gone for Kids Nasal Swab Remedy 0.33 FL OZ (10 mL) tubes, UPC Code 860002022116
- Manufacturer
- Buzzagogo, LLC
- Category
- Drug — Nasal Remedy
- Hazard
- yeast
- mold
- bacillus-cereus
- microbial-contamination
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2006491
- Exp. Date 08/24
Distribution
Distribution scope not specified by the agency.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27
- LowPrimidone Tablets Recalled for Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27